Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma

[1]  Harini Veeraraghavan,et al.  Reliability of tumor segmentation in glioblastoma: impact on the robustness of MRI-radiomic features. , 2019, Medical physics.

[2]  S. Park,et al.  Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement , 2019, European Radiology.

[3]  Maryellen L. Giger,et al.  Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling , 2019, Cancer Imaging.

[4]  Caixia Wu,et al.  Prediction and evaluation of neoadjuvant chemotherapy using the dual mechanisms of 99mTc-MIBI scintigraphy in patients with osteosarcoma , 2019, Journal of bone oncology.

[5]  S. Hopyan,et al.  Usefulness of diffusion-weighted MRI in the initial assessment of osseous sarcomas in children and adolescents , 2019, Pediatric Radiology.

[6]  G. Carle,et al.  Role of autophagy in osteosarcoma , 2019, Journal of bone oncology.

[7]  Daniel Balvay,et al.  Gray-level discretization impacts reproducible MRI radiomics texture features , 2019, PloS one.

[8]  E. V. van Beek,et al.  Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer: Improvements Using Radiomics. , 2019, Journal of thoracic imaging.

[9]  G. Liberman,et al.  Differentiation between vasogenic edema and infiltrative tumor in patients with high‐grade gliomas using texture patch‐based analysis , 2018, Journal of magnetic resonance imaging : JMRI.

[10]  L. Mainardi,et al.  Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions , 2018, Journal of magnetic resonance imaging : JMRI.

[11]  A. Degnan,et al.  Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors. , 2018, Clinical imaging.

[12]  Dengwang Li,et al.  Reproducibility of radiomic features with GrowCut and GraphCut semiautomatic tumor segmentation in hepatocellular carcinoma , 2017 .

[13]  A. Madabhushi,et al.  Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi‐institutional study , 2017, Journal of magnetic resonance imaging : JMRI.

[14]  J. Wiemels,et al.  Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents , 2017, Pediatric blood & cancer.

[15]  M. Nogueira-Barbosa,et al.  Diagnostic performance of magnetic resonance imaging in the assessment of periosteal reactions in bone sarcomas using conventional radiography as the reference , 2017, Radiologia brasileira.

[16]  D. Dong,et al.  Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma , 2017, Clinical Cancer Research.

[17]  Giovanna Rizzo,et al.  Texture analysis of medical images for radiotherapy applications. , 2017, The British journal of radiology.

[18]  L. Doyle,et al.  Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone. , 2016, Surgical oncology clinics of North America.

[19]  L. Schwartz,et al.  Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC , 2016, Scientific Reports.

[20]  Yanqi Huang,et al.  Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer. , 2016, Radiology.

[21]  Jian-sheng Zhou,et al.  Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma , 2016, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[22]  P. Marsden,et al.  False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review , 2015, PloS one.

[23]  Jinzhong Yang,et al.  IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. , 2015, Medical physics.

[24]  Gary S Collins,et al.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.

[25]  K. S. Hall,et al.  Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  J. Laredo,et al.  Periosteum: Characteristic imaging findings with emphasis on radiologic-pathologic comparisons , 2015, Skeletal Radiology.

[27]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[28]  Bal Sanghera,et al.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.

[29]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[30]  E. Álava,et al.  Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  F. Costa,et al.  Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors. , 2011, Magnetic resonance imaging clinics of North America.

[32]  S. Ferrari,et al.  Emerging drugs for high-grade osteosarcoma , 2010, Expert opinion on emerging drugs.

[33]  M. Ines Boechat,et al.  Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review , 2009, Pediatric Radiology.

[34]  A. Rutman,et al.  Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. , 2009, European journal of radiology.

[35]  M. van Glabbeke,et al.  Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. , 2007, Journal of the National Cancer Institute.

[36]  Mathias Langer,et al.  Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas , 2006, Pediatric Radiology.

[37]  Piero Picci,et al.  Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy , 2006, Cancer.

[38]  M. Gonen,et al.  Concordance probability and discriminatory power in proportional hazards regression , 2005 .

[39]  Jiang Gui,et al.  Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data , 2005, Bioinform..

[40]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[41]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[44]  Z. Ying,et al.  A Class of Weighted Log-Rank Tests for Survival Data When the Event is Rare , 2000 .